Sign in
Welcome! Log into your account
Forgot your password? Get helpPrivacy PolicyPassword recovery
Recover your password
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology NewsHomeWebinarsUpcomingEmerging Trends in Fluid Transfers and Freeze-Thaw Workflows
Credit: Huntstock / Getty Images
Alex Fuchs
Director of Product Innovation
Single Use Support
Colder Products Company
Panelist
Alex Fuchs
Alexander Fuchs is the director of product innovation at Single Use Support. Due to his highly technical education and intensive insights, he has a wide range of experience and knowledge in various industries, such as jewelry, manufacturing, and biopharma, as well as multiple areas of activity. Passionate about automation, engineering, and process management, Alexander contributes to the innovative focus of advancing fluid and cold chain management within the biopharmaceutical industry.
Jascha Rosenbaum
Regional Director for Applications & Business Development
Colder Products Company
Panelist
Jascha Rosenbaum
Jascha Rosenbaum is the regional director for applications and business development in Europe. Jascha holds a master’s degree in chemical engineering, and he has worked in the single-use industry for the last 10 years in both the U.S. and Europe. He has supported some of the largest biopharmaceutical manufacturers across Europe, where he has experience at every stage of single-use solutions.
Broadcast Date:Tuesday, October 20, 2026
- Time:08:00 PDT, 11:00 EDT, 15:00 GMT
In cell and gene therapy manufacturing, fluid transfer and freeze-thaw workflows are paramount to process efficiency, product quality, and operational flexibility. From scaling and closed-system processing to automation and the growing use of cryopreservation, manufacturers are rethinking how materials move through the process—both during manufacturing and between unit operations.
In thisGENwebinar, our expert speakers will discuss the latest trends, challenges, and innovations shaping fluid transfer and freeze-thaw workflows. The panel will explore how cell and gene therapy manufacturers are addressing complex process requirements while reducing manual interventions, minimizing contamination risk, improving workflow efficiency, and preparing processes for scale. Key takeaways from the webinar include:
- Emerging approaches to fluid transfers,
- Single-use technologies and sterile connections,
- Freeze-thaw considerations,
- Automation and closed processing,
- Strategies for building more flexible and robust workflows for cell and gene therapy manufacturing
A live Q&A session will follow the conversation offering you a chance to pose questions to our expert panelists.
Produced with support from:
Also of Interest
Advancing Cell Therapy for Cardiovascular DiseaseStockWatch: Novo's 2030 Strategy Underwhelms Investors at Capital Markets DayGenes Involved in Flatworm Brain Regeneration IdentifiedH5N1 Spreads Among Australian Wildlife as Flu Season Ramps UpPrecure Selects Helix as Multiomics Lab and AI Tools ProviderAndelyn Curator Biomanufacturing Platform Supports Fayuvi Gene Therapy ApprovalRelated Media
Data Integrity as the Foundation for AISmall Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and SustainabilityBeyond the Technology: AI Readiness in Regulated LaboratoriesEnablingIn VivoLentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical ReadinessAACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven EraAACR 2026: A Video Update from San DiegoCopyright © 2026 Sage Publications or its affiliates, licensors, or contributors. All rights reserved, including those for text and data mining and training of large language models, artificial intelligence technologies, or similar technologies.
MORE STORIES
